Carrier Screening and Medicare Rebate
This course provides Australian healthcare professionals with a practical overview of genetic carrier screening and the Medicare rebate. It covers key conditions, patient selection, result interpretation, counselling considerations, and clinical pathways, supporting informed decision-making and effective integration into routine care.
.jpg)
Learning Outcomes
What you'll learn
- Explain the principles and purpose of genetic carrier screening in reproductive care
- Identify key conditions included in carrier screening and their clinical relevance
- Determine appropriate candidates for screening and optimal timing (preconception or antenatal)
- Interpret carrier screening results and understand residual risk and limitations
- Apply knowledge of Medicare rebate eligibility and Australian guidelines to clinical practice
- Communicate screening options and results effectively with patients
- Outline reproductive options and referral pathways for carrier couples
- Integrate carrier screening into routine healthcare practice with confidence
Stay updated with our


Learning Outcomes
What you'll learn
- Explain the principles and purpose of genetic carrier screening in reproductive care
- Identify key conditions included in carrier screening and their clinical relevance
- Determine appropriate candidates for screening and optimal timing (preconception or antenatal)
- Interpret carrier screening results and understand residual risk and limitations
- Apply knowledge of Medicare rebate eligibility and Australian guidelines to clinical practice
- Communicate screening options and results effectively with patients
- Outline reproductive options and referral pathways for carrier couples
- Integrate carrier screening into routine healthcare practice with confidence
Stay updated with our


Training Overview
- Introduction to Genetic Carrier Screening
- Conditions Included in Carrier Screening
- Indications and Target Population
- Screening Process and Interpretation of Results
- Medicare Rebate and Australian Guidelines
- Counselling, Ethical Considerations and Communication
- Clinical Pathways and Reproductive Options
- Practical Implementation in Clinical Practice
- Summary
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Top reviews
No reviews yet.
You May Also Like
Are you a qualified
Trainer or Instructor?
Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.
Refer a Friend &
Earn Rewards.
Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.
Frequently asked questions
No, it is optional but recommended for individuals planning pregnancy or in early pregnancy.
No, Medicare covers only CF, SMA, and Fragile X. Expanded panels are usually self-funded.
No, a small residual risk remains even after a negative result.
Usually one partner is tested first. If positive, the other partner is tested.
.jpg)
.jpg)
.jpg)



